Kite Pharma Inc (KITE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
Sales | 22,170 | 17,258 | 0 | 0 | 0 |
Gross Profit | 22,170 | 17,258 | N/A | N/A | N/A |
Operating Expenses | 295,357 | 121,208 | 36,658 | 6,427 | 2,581 |
Operating Income | -273,187 | -103,950 | -36,658 | -6,427 | -2,581 |
Interest Expense | 13 | 26 | 6,269 | 4 | 1 |
Other Income | 3,236 | 2,323 | 358 | 65 | 9 |
Pre-tax Income | -269,964 | -101,653 | -42,569 | -6,366 | -2,573 |
Income Tax | -2,894 | N/A | N/A | N/A | N/A |
Net Income Continuous | -267,070 | -101,653 | -42,569 | -6,366 | -2,573 |
Net Income | $-267,070 | $-101,653 | $-42,569 | $-6,366 | $-2,573 |
EPS Basic Total Ops | -5.46 | -2.33 | -1.91 | -1.43 | -0.48 |
EPS Basic Continuous Ops | -5.46 | -2.33 | -1.87 | -1.16 | -0.48 |
EPS Diluted Total Ops | -5.46 | -2.33 | -1.91 | -1.43 | -0.48 |
EPS Diluted Continuous Ops | -5.46 | -2.33 | -1.87 | -1.16 | -0.48 |
EPS Diluted Before Non-Recurring Items | -5.46 | -2.33 | -1.91 | -0.22 | N/A |
EBITDA(a) | $-260,972 | $-98,714 | $-36,396 | $-6,410 | $-2,572 |